Literature DB >> 11927203

Incidence of chronic atrial fibrillation in general practice and its treatment pattern.

Ana Ruigómez1, Saga Johansson, Mari Ann Wallander, Luis Alberto García Rodríguez.   

Abstract

The object of this article was to estimate the incidence rate of chronic atrial fibrillation (AF) in a general practice setting, to identify factors predisposing to its occurrence, and to describe treatment patterns in the year following the diagnosis. The method used was a population-based cohort study using the General Practice Research Database (GPRD) in the UK. We identified patients aged 40-89 years with a first ever recorded diagnosis of AF. The diagnosis was validated through a questionnaire sent to the general practitioners. A nested case-control analysis was performed to assess risk factors for AF using 1,035 confirmed incident cases of chronic AF and a random sample of 5,000 controls from the original source population. The incidence rate of chronic AF was 1.7 per 1,000 person-years, and increased markedly with age. The age adjusted rate ratio among males was 1.4 (95% CI 1.2-1.6). The major risk factors were age, high BMI, excessive alcohol consumption, and prior cardiovascular comorbidity, in particular, valvular heart disease and heart failure. Digoxin was used in close to 70% of the patients, and close to 15% did not receive any antiarrhythmic treatment. Close to 40% did not receive either warfarin or aspirin in the 3 months period after the diagnosis. Among the potential candidates for anticoagulation only 22% of those aged 70 years or older were prescribed warfarin in comparison to 49% among patients aged 40-69 years. Chronic AF is a disease of the elderly, with women presenting a lower incidence rate than men specially in young age. Age, weight, excessive alcohol consumption, and cardiovascular morbidity were the main independent risk factors for AF. Less than half of patients with chronic AF and no contraindications for anticoagulation received warfarin within the first trimester after the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927203     DOI: 10.1016/s0895-4356(01)00478-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  52 in total

1.  Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study.

Authors:  Rachel R Huxley; Alvaro Alonso; Faye L Lopez; Kristian B Filion; Sunil K Agarwal; Laura R Loehr; Elsayed Z Soliman; James S Pankow; Elizabeth Selvin
Journal:  Heart       Date:  2011-09-19       Impact factor: 5.994

Review 2.  Recent developments in atrial fibrillation.

Authors:  M Bilal Iqbal; Anil K Taneja; Gregory Y H Lip; Marcus Flather
Journal:  BMJ       Date:  2005-01-29

3.  A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland.

Authors:  Niamh F Murphy; Colin R Simpson; Pardeep S Jhund; Simon Stewart; Michelle Kirkpatrick; Jim Chalmers; Kate MacIntyre; John J V McMurray
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

Review 4.  Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

Authors:  Rachel R Huxley; Kristian B Filion; Suma Konety; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2011-04-27       Impact factor: 2.778

Review 5.  Validity of diagnostic coding within the General Practice Research Database: a systematic review.

Authors:  Nada F Khan; Sian E Harrison; Peter W Rose
Journal:  Br J Gen Pract       Date:  2010-03       Impact factor: 5.386

Review 6.  The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications.

Authors:  Bernard J Gersh; Teresa S M Tsang; James B Seward
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

7.  Prevalence and predictors of atrial fibrillation among patients undergoing bariatric surgery.

Authors:  M Benjamin Shoemaker; Sanaz Gidfar; Daniel C Pipilas; Robyn A Tamboli; Eleonora Savio Galimberti; D Brandon Williams; Ronald H Clements; Dawood Darbar
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

Review 8.  Alcohol intake and noncoronary cardiovascular diseases.

Authors:  Kenneth Mukamal
Journal:  Ann Epidemiol       Date:  2007-05       Impact factor: 3.797

9.  Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.

Authors:  Axel Brandes; Mikkel Overgaard; Liane Plauborg; Christian Dehlendorff; Frede Lyck; Jørgen Peulicke; Søren Vinther Poulsen; Steen Husted
Journal:  Clin Cardiol       Date:  2013-05-13       Impact factor: 2.882

10.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.